Systemic sclerosis following oral contraception.
Beretta
Lorenzo
L
Caronni
Monica
M
Scorza
Raffaella
R
D000328:Adult; D000736:Androstenes / Q000009:adverse effects*; D000974:Antibodies, Antinuclear / Q000097:blood; D015415:Biomarkers / Q000097:blood; D002503:Centromere / Q000276:immunology; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D006710:Homocysteine / Q000097:blood; D006801:Humans; D008599:Menstruation Disturbances / Q000188:drug therapy; D020678:Microscopic Angioscopy; D000451:Mineralocorticoid Receptor Antagonists / Q000009:adverse effects*; D045167:Progesterone Congeners / Q000009:adverse effects*; D012595:Scleroderma, Systemic / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis
D000736:Androstenes; D000974:Antibodies, Antinuclear; D015415:Biomarkers; D000451:Mineralocorticoid Receptor Antagonists; D045167:Progesterone Congeners; D006710:Homocysteine; C035144:drospirenone